Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698152 · ClinicalTrials.gov registry record
A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 149
- Enrollment target
- 5
- Study locations
NCT00698152: Completed study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
NCT00698152 is a study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Zimmer Biomet. The registered enrollment target is 149 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698152, a study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this data collection is to determine long term survival rate of ArComXL® highly cross-linked polyethylene
Primary Outcome
Patient questionnaire
Conditions Studied
Study Locations (5)
Ohio
- The Orthopaedic Institute of Ohio - Lima
- Ohio Valley Orthopedic and Sports Medicine - West Chester
Maryland
- The Orthopaedic Center - Rockville
Pennsylvania
- Scranton Orthopaedic Specialists, PC - Dickson City
Texas
- Texas Orthopedic Specialists, PA - Grapevine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2006-01-23 |
| Est. Completion | 2016-01-15 |
What the finished NCT00698152 record still lists
NCT00698152 is an observational study that tracks outcomes without assigning an intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT00698152 lists 5 locations in 4 states (Ohio, Maryland, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT00698152 about?
NCT00698152 is a clinical study titled "A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement". The purpose of this data collection is to determine long term survival rate of ArComXL® highly cross-linked polyethylene
What is the current status of trial NCT00698152?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2006-01-23. Estimated completion is 2016-01-15.
What conditions does trial NCT00698152 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis.
Who is sponsoring clinical trial NCT00698152?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00698152 being conducted?
This trial has 5 study locations across Maryland, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00698152's enrollment target sits among peer trials
149 101st of 197 higher than 97 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI